Ulta (ULTA) CHRO receives new restricted stock and 4,912 stock options

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Ulta Beauty, Inc. Chief Human Resources Officer Anita Jane Ryan received equity awards that increase her direct stake in the company. She was granted 1,443 shares of restricted stock that vest 100% on March 15, 2029, adding to her long-term share ownership. She also received stock options covering 4,912 shares of common stock at an exercise price of $522.71 per share, vesting in 25% annual increments starting March 15, 2027 and continuing through March 15, 2030. Following these awards, she directly owns 9,141 shares of Ulta Beauty common stock.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Ryan Anita Jane

Role Chief Human Resources Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	4,912	$0.00	--
Grant/Award	Common Stock	1,443	$0.00	--

Holdings After Transaction: Stock Option (right to buy) — 4,912 shares (Direct); Common Stock — 9,141 shares (Direct)

Footnotes (1)

Represents grant of 1,443 shares of restricted stock, vesting 100% on March 15, 2029. The options, representing an initial right to purchase a total of 4,912 shares, vesting in 25% annual increments beginning March 15, 2027 and each anniversary thereafter through March 15, 2030.

Key Figures

Restricted stock grant: 1,443 shares Stock options granted: 4,912 shares Option exercise price: $522.71/share +5 more

8 metrics

Restricted stock grant 1,443 shares Grant to CHRO, vesting March 15, 2029

Stock options granted 4,912 shares Options on common stock granted March 31, 2026

Option exercise price $522.71/share Exercise price for 4,912 stock options

Post-grant share holdings 9,141 shares Common stock directly owned after restricted stock award

Restricted stock vesting date March 15, 2029 100% vesting for 1,443 restricted shares

Option vesting period start March 15, 2027 First 25% of options vest

Option vesting period end March 15, 2030 Final 25% of options vest

Option expiration date March 31, 2036 Expiration of right to exercise 4,912 options

Key Terms

restricted stock, Stock Option (right to buy), exercise price, vesting in 25% annual increments, +1 more

5 terms

restricted stock financial

"Represents grant of 1,443 shares of restricted stock, vesting 100% on March 15, 2029."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Stock Option (right to buy) financial

"security_title: Stock Option (right to buy)"

exercise price financial

"conversion_or_exercise_price: 522.7100"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting in 25% annual increments financial

"vestering in 25% annual increments beginning March 15, 2027 and each anniversary thereafter"

grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Form 4 Insider Transactions: What Each Field Means →

04/02/2026 - 04:47 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ryan Anita Jane

(Last)

(First)

(Middle)

1000 REMINGTON BLVD., SUITE 120

(Street)

BOLINGBROOK

ILLINOIS

60440

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ulta Beauty, Inc. [ ULTA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Human Resources Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/31/2026		A		1,443⁽¹⁾	A	$0	9,141	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$522.71	03/31/2026		A		4,912		⁽²⁾	03/31/2036	Common Stock	4,912	$0	4,912	D

Explanation of Responses:

1. Represents grant of 1,443 shares of restricted stock, vesting 100% on March 15, 2029.

2. The options, representing an initial right to purchase a total of 4,912 shares, vesting in 25% annual increments beginning March 15, 2027 and each anniversary thereafter through March 15, 2030.

	/s/ Rene G. Casares, as attorney-in-fact for Anita Jane Ryan	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What equity awards did Ulta (ULTA) grant to CHRO Anita Jane Ryan?

Ulta granted Anita Jane Ryan 1,443 shares of restricted stock and stock options on 4,912 shares. The restricted stock vests in 2029, while the options vest in annual increments from 2027 to 2030 at a $522.71 exercise price.

When do Anita Jane Ryan’s restricted Ulta (ULTA) shares vest?

Her 1,443 restricted Ulta shares vest 100% on March 15, 2029. Until then, they are subject to vesting conditions, typically continued employment or performance, aligning her incentives with Ulta’s long-term results over several years.

What are the terms of Anita Jane Ryan’s new Ulta (ULTA) stock options?

She received options on 4,912 Ulta shares with a $522.71 exercise price. These options vest in 25% annual increments beginning March 15, 2027 and on each anniversary through March 15, 2030, encouraging multi-year retention.

How many Ulta (ULTA) shares does Anita Jane Ryan own after these grants?

After the March 31, 2026 grants, Anita Jane Ryan directly owns 9,141 Ulta common shares. This figure reflects her updated direct holding following the award of 1,443 restricted shares reported in the Form 4 filing.

Are Anita Jane Ryan’s Ulta (ULTA) transactions open-market buys or compensation grants?

These Ulta transactions are compensation-related grants, not open-market purchases. Both the restricted stock and stock options were reported with code A, indicating grants or awards, and carried a zero dollar transaction price per share.